Completed
Parathyroid Hormone Regulation in Pseudohypoparathyroidism: Sodium Citrate and Calcium Gluconate Infusions
What is being collected
Data Collection
Who is being recruted
Bone Diseases+13
+ Bone Diseases, Metabolic
+ Calcium Metabolism Disorders
Over 12 Years
How is the trial designed
Observational
Study Start: May 1993
Summary
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Study start date: May 1, 1993
Actual date on which the first participant was enrolled.PROTOCOL OUTLINE: Patients are tested for parathyroid hormone response following sequential graded intravenous infusions of sodium citrate and calcium gluconate. Assays include ionized calcium and intact parathyroid hormone.
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 12 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Bone DiseasesBone Diseases, MetabolicCalcium Metabolism DisordersMetabolic DiseasesMetabolism, Inborn ErrorsMetal Metabolism, Inborn ErrorsMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsDisease AttributesGenetic Diseases, InbornEndocrine System DiseasesPseudohypoparathyroidismRare Diseases
Criteria
PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Pseudohypoparathyroidism, i.e.: Renal resistance to parathyroid hormone OR Albright hereditary osteodystrophy No other illness unless related to pseudohypoparathyroidism No pregnant women
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers